Loading...
Cell Therapy Expansion Into Graft Versus Host Disease Will Transform Long Term Earnings Power
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
42.8%7D
-1.8%1Y
42.8%7D
-1.8%You can edit this narrative until Dec 15 10:10 AM. Then, changes will post as Updates.